Drug Profile
Usher syndromes - gene therapies - IVERIC bio
Alternative Names: mini-USH2A; mini-USH2A- Iveric; Minigene Programmes - IVERIC bioLatest Information Update: 09 Jan 2024
Price :
$50
*
At a glance
- Originator University of Massachusetts Medical School
- Developer IVERIC bio
- Class Eye disorder therapies; Gene therapies
- Mechanism of Action Gene transference
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Research Usher syndromes